IMV Technologies acquires Nelson Medical
Reproduction biotechnologies company, IMV Technologies, has completed the acquisition of Nelson Medical, a Chinese manufacturer of artificial insemination products for livestock and companion animals.
Since 2000, Nelson Medical has played an integral part in the artificial insemination industry by providing producers worldwide with products that deliver exceptional quality and performance.
With this acquisition, IMV Technologies increases its manufacturing capabilities and strengthens its presence in China and South-East Asia. The company will also broaden its product offering to better serve its customer base worldwide.
Ms Ronia Cao, founder and President of Nelson Medical will drive the medical strategic business unit in the newly opened Shanghai-based Nelson manufacturing facility. The facility offers increased cleanroom and manufacturing capacity for both the veterinarian and human markets. Mr Eric Pan, General Manager of IMV Technologies China will lead all IMV-related operations within China as well as Nelson’s veterinary export sales.
This strategic acquisition will create greater efficiencies for IMV Technologies’ worldwide customers and partners and accelerate the delivery of complementing key animal assisted reproduction products.
Join 31,000+ subscribers
Subscribe to our newsletter to stay updated about all the need-to-know content in the poultry sector, three times a week.
